Iovance Biotherapeutics, Inc.

IOVA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$10.02+1.52%

2026-09-17

Financials

Valuation Metrics

Iovance Biotherapeutics, Inc.'s Market Cap is $4.47B. At end of 2025 it was $1.11B. Ranked #1441 of 3,121 in US market (top 46%), #499 of 1,463 on NASDAQ (top 34%), #86 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 32%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$4.47B	US#1,441/3,121 Sec#86/266
Revenue	$325M	US#2,425/3,121 Sec#91/266
Net Income	$-290M	US—/3,121 Sec—/266
Total Assets	$916M	US#2,519/3,121 Sec#108/266
Net Assets	$736M	US#1,978/3,121 Sec#82/266
Value
P/B	6.08x	US#2,358/3,121 Sec#160/266
P/S	13.77x	US#2,770/3,121 Sec#126/266
FCF Yield	-6.62%	US—/3,121 Sec—/266
Profitability
ROE	-39.33%	US#2,625/3,121 Sec#135/266
ROA	-31.62%	US#2,895/3,121 Sec#160/266
Op. Margin	-92.72%	US#2,734/3,121 Sec#123/266
Revenue Growth	34.55%	US#359/3,121 Sec#58/266
Financial Health
Debt Ratio	24.39%	US#273/3,121 Sec#93/266
Total Debt	$46M	US#2,631/3,121 Sec#157/266
FCF	$-296M	US#2,846/3,121 Sec#231/266
Cash	$111M	US#2,168/3,121 Sec#165/266
Current Ratio	4.34x	US#542/3,121 Sec#162/266
Performance
1Y Return	351.35%	US#23/3,121 Sec#11/266
1M Return	42.53%	US#19/3,121 Sec#6/266
From 52W High	-8.74%	US#607/3,121 Sec#45/266
1Y MDD	-39.00%	US#1,962/3,121 Sec#134/266
Trading
Volume	23,922,584 shares	US#50/3,121 Sec#3/266
Trading Value	$247M	US#377/3,121 Sec#19/266
Per Share
EPS	$-0.65	US—/3,121 Sec—/266
BPS	$1.65	US#2,610/3,121 Sec#186/266